Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP.

NAD(P)H-dependent d-xylose reductase is a homodimeric oxidoreductase that belongs to the aldo-keto reductase superfamily. The enzyme has the special function to catalyze the first step in the assimilation of xylose into yeast metabolic pathways. Performing this function via reducing the open chain xylose to xylitol, the xylose reductase of Pichia stipitis is one of the most important enzymes that can be used to construct recombinant Saccharomyces cerevisiae strain for utilizing xylose and producing alcohol. To investigate into the interaction mechanism of the enzyme with its ligand NAD and NADP, the 3D structure was developed for the NAD(P)H-dependent d-xylose reductase from P. stipitis. With the 3D structure, the molecular docking operations were conducted to find the most stable bindings of the enzyme with NAD and NADP, respectively. Based on these results, the binding pockets of the enzyme for NAD and NADP have been explicitly defined. It has been found that the residues in forming the binding pockets for both NAD and NADP are almost the same and mainly hydrophilic. These findings may be used to guide mutagenesis studies, providing useful clues to modify the enzyme to improve the utilization of xylose for producing alcohol. Also, because human aldose reductases have the function to reduce the open chain form of glucose to sorbitol, a process physiologically significant for diabetic patients at the time that their blood glucose levels are elevated, the information gained through this study may also stimulate the development of new strategies for therapeutic treatment of diabetes.

[1]  R. Battiti,et al.  Simulated annealing and Tabu search in the long run: A comparison on QAP tasks☆ , 1994 .

[2]  K. Chou Structural bioinformatics and its impact to biomedical science. , 2004, Current medicinal chemistry.

[3]  Kuo-Chen Chou,et al.  Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives. , 2005, Biochemical and biophysical research communications.

[4]  K. Chou,et al.  Simulated annealing approach to the study of protein structures. , 1991, Protein engineering.

[5]  Louise Wickham,et al.  Post-translational Processing of β-Secretase (β-Amyloid-converting Enzyme) and Its Ectodomain Shedding , 2001, The Journal of Biological Chemistry.

[6]  N. Green,et al.  The crystal structure of an aldehyde reductase Y50F mutant-NADP complex and its implications for substrate binding. , 2001, Chemico-biological interactions.

[7]  B. Nidetzky,et al.  Fine tuning of coenzyme specificity in family 2 aldo‐keto reductases revealed by crystal structures of the Lys‐274 → Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NAD+ and NADP+ , 2005, FEBS letters.

[8]  Fabrice Leclerc,et al.  Effective atom volumes for implicit solvent models: comparison between Voronoi volumes and minimum fluctuation volumes , 2001, J. Comput. Chem..

[9]  C. Hollenberg,et al.  Cloning and expression in Saccharomyces cerevisiae of the NAD(P)H-dependent xylose reductase-encoding gene (XYL1) from the xylose-assimilating yeast Pichia stipitis. , 1991, Gene.

[10]  K. Chou,et al.  Progress in computational approach to drug development against SARS. , 2006, Current medicinal chemistry.

[11]  Elaine C. Meng,et al.  Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities , 1994, J. Comput. Aided Mol. Des..

[12]  Kuo-Chen Chou,et al.  Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase , 2004, Analytical Biochemistry.

[13]  T. Penning,et al.  The aldo-keto reductase superfamily homepage. , 2003, Chemico-biological interactions.

[14]  Gerhard Wagner,et al.  Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment , 1998, Cell.

[15]  K. Chou,et al.  Prediction of the tertiary structure of a caspase‐9/inhibitor complex , 2000, FEBS letters.

[16]  Kuo-Chen Chou,et al.  Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points , 2004, J. Chem. Inf. Model..

[17]  Fred Glover,et al.  Tabu Search: A Tutorial , 1990 .

[18]  K. Chou,et al.  Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide , 2004, Peptides.

[19]  K. Chou,et al.  Molecular insights of SAH enzyme catalysis and implication for inhibitor design. , 2007, Journal of theoretical biology.

[20]  K. Chou,et al.  Graphic rules in steady and non-steady state enzyme kinetics. , 1989, The Journal of biological chemistry.

[21]  Kuo-Chen Chou,et al.  Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein. , 2005, Journal of proteome research.

[22]  Kuo-Chen Chou,et al.  Inhibitor design for SARS coronavirus main protease based on "distorted key theory". , 2007, Medicinal chemistry (Shariqah (United Arab Emirates)).

[23]  J. Kinoshita,et al.  The Pharmacology of Aldose Reductase Inhibitors , 1985 .

[24]  Kuo-Chen Chou,et al.  Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. , 2006, Biochemical and biophysical research communications.

[25]  Kuo-Chen Chou,et al.  Insights from modeling the tertiary structure of human BACE2. , 2004, Journal of proteome research.

[26]  Louise Wickham,et al.  Post-translational processing of β-secretase (BACE) and its ectodomain shedding: the pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid Aβ production , 2001 .

[27]  T. A. Jones,et al.  Using known substructures in protein model building and crystallography. , 1986, The EMBO journal.

[28]  Kuo-Chen Chou,et al.  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS , 2003, Biochemical and Biophysical Research Communications.

[29]  D. Goodsell,et al.  Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock , 2002, Proteins.

[30]  Ana Martínez,et al.  Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders , 2000 .

[31]  Kuo-Chen Chou,et al.  Identification of the N‐terminal functional domains of Cdk5 by molecular truncation and computer modeling , 2002, Proteins.

[32]  M. Lewis,et al.  Comparative anatomy of the aldo-keto reductase superfamily. , 1997, The Biochemical journal.

[33]  Kuo-Chen Chou,et al.  3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. , 2007, Biochemical and biophysical research communications.

[34]  K. Chou,et al.  Prediction of the tertiary structure and substrate binding site of caspase‐8 , 1997, FEBS letters.

[35]  K. Chou,et al.  Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases. , 2007, Biochemical and biophysical research communications.

[36]  Kuo-Chen Chou,et al.  Energy of stabilization of the right-handed βαβ crossover in proteins☆ , 1989 .

[37]  V. Garsky,et al.  The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain* , 2001, The Journal of Biological Chemistry.

[38]  C. Grimshaw Aldose reductase: model for a new paradigm of enzymic perfection in detoxification catalysts. , 1992, Biochemistry.

[39]  Characterization and purification of a mammalian osmoregulatory protein, aldose reductase, induced in renal medullary cells by high extracellular NaCl. , 1987, The Journal of biological chemistry.

[40]  K D Watenpaugh,et al.  A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator. , 1999, Biochemical and biophysical research communications.

[41]  Todd J. A. Ewing,et al.  DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..

[42]  Kuo-Chen Chou,et al.  Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. , 2004, Biochemical and biophysical research communications.

[43]  K. Chou Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems. , 2020, Biophysical chemistry.

[44]  D. Haltrich,et al.  Noncovalent enzyme-substrate interactions in the catalytic mechanism of yeast aldose reductase. , 1998, Biochemistry.

[45]  Kuo-Chen Chou,et al.  Prediction of the Tertiary Structure of the β-Secretase Zymogen☆ , 2002 .

[46]  Hung Lee,et al.  Review: The structure and function of yeast xylose (aldose) reductases , 1998, Yeast.

[47]  K. Chou,et al.  The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties , 2006, Marine Drugs.

[48]  K.-C. Chou,et al.  Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy , 2006, Amino Acids.

[49]  K.-C. Chou,et al.  Anti-SARS drug screening by molecular docking , 2006, Amino Acids.

[50]  Kuo-Chen Chou,et al.  Molecular modeling studies of peptide drug candidates against SARS. , 2006, Medicinal chemistry (Shariqah (United Arab Emirates)).

[51]  Kuo-Chen Chou Insights from modeling three-dimensional structures of the human potassium and sodium channels. , 2004, Journal of proteome research.

[52]  Kuo-Chen Chou,et al.  Modeling the tertiary structure of human cathepsin-E. , 2005, Biochemical and biophysical research communications.

[53]  Kuo-Chen Chou,et al.  Molecular therapeutic target for type-2 diabetes. , 2004, Journal of proteome research.

[54]  David S. Goodsell,et al.  Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..

[55]  L. Tsai,et al.  Structure and Regulation of the CDK5-p25nck5a Complex , 2001 .

[56]  Kuo-Chen Chou,et al.  Insights from Modeling the 3D Structure of DNA−CBF3b Complex , 2005 .

[57]  T. L. Blundell,et al.  Knowledge-based prediction of protein structures and the design of novel molecules , 1987, Nature.

[58]  Kuo-Chen Chou,et al.  Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor. , 2004, Biochemical and biophysical research communications.

[59]  Kuo-Chen Chou,et al.  The convergence‐divergence duality in lectin domains of selectin family and its implications , 1995, FEBS letters.